| related words |
| chemofx |
| nicvax |
| sickle |
| reformulate |
| ndas |
| transponder |
| amigal |
| thalidomide |
| emerges |
| pdx |
| prostate |
| nanocrystalline |
| alferon |
| untargeted |
| chemistry |
| nicotine |
| tolamba |
| xchange |
| medpulser |
| fusilev |
|
| related documents |
| 946644--3/17/2008--HEMISPHERX_BIOPHARMA_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {financial, litigation, operation} |
| {capital, credit, financial} |
| {provision, law, control} |
| {acquisition, growth, future} |
| {stock, price, operating} |
| {debt, indebtedness, cash} |
| {competitive, industry, competition} |
| {investment, property, distribution} |
| {control, financial, internal} |
| {gas, price, oil} |
| {tax, income, asset} |
| {loan, real, estate} |
| {stock, price, share} |
| {loss, insurance, financial} |
| {interest, director, officer} |
| {cost, regulation, environmental} |
| {system, service, information} |
| {regulation, government, change} |
|